GMAB Genmab A/s (GMAB) Insider Trading, Ownership & Congress Trades
What the filings say about GMAB
Genmab A/s insider trades (Form 4)
No insider purchases or sales are on record for GENMAB A/S in the period covered. Source: SEC Form 4 filings, as of 2026-10-28.
Foreign private issuer: its insiders are exempt from SEC Form 4 and report in the home market, so their buys and sells do not appear here.
no insider purchases or sales on record
Watch GMAB
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
Who owns GMAB: institutional holders (13F)
Congress trades in GMAB
Activist and 5% holders (13D/13G)
GMAB planned insider sales (Form 144)
GMAB mutual fund holders (N-PORT)
GMAB financials
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Net income | $963.0M | $7.8B | $4.4B | $5.5B |
GMAB Stock Sonar score 2/7 axes
Find similar shapesCompare2 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
GMAB filings, in plain words
Have members of Congress traded GMAB?
Yes, but not in the year to 2026-10-28; the latest on record is a purchase by Josh Gottheimer dated 2025-01-16.
Read the full summary
Members of Congress have disclosed trades in GMAB, none in the last year; the latest on record is a purchase by Josh Gottheimer dated 2025-01-16. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.

